CEO Michael Fraser Leading Pathology’s Future with Innovation and Advocacy

As the CEO of a professional medical organization, it is crucial to have a profound grasp of the evolving landscape of technologies, practices, and fundamental theories that impact patient outcomes. One leader who stands at the vanguard of this dynamic environment is Michael Fraser, the CEO of the College of American Pathologists (CAP) located in Northfield, Illinois.

The College of American Pathologists (CAP) is renowned for its provision of laboratory accreditation and proficiency testing programs for board-certified pathologists, aside from advocating for the industry and educating the public on the latest breakthroughs in pathology and laboratory medicine. Established in 1946, CAP has continuously adapted to the ever-changing realms of medicine, technology, and pathology. Fraser shares insights on how the organization has spearheaded efforts to tackle new challenges aimed at enhancing patient outcomes.

Boasting over 25 years of experience in medical association management, Fraser has an impressive leadership record in the healthcare domain. Prior to joining CAP, he served as the CEO of the Association of State and Territorial Health Officials, where he played a pivotal role in shaping public health policies across 59 states and territories.

In a recent Q&A session, Fraser delves into the key initiatives he has spearheaded at CAP since assuming the role of CEO in March of last year. He mentions a robust focus on assisting pathologists in navigating through the advent of digital pathology and artificial intelligence in healthcare, thereby exploring how these tools can augment their practices. Additionally, efforts are being directed towards brainstorming novel reimbursement and regulatory models aimed at supporting the adoption of these innovative technologies. CAP is also actively engaged in addressing a significant FDA regulation concerning laboratory-developed tests, collaborating with stakeholders in Washington to advocate for its members through various legislative, regulatory, and legal avenues.

Moreover, CAP is investing in the future of pathology through its “Future Pathologist Champions” initiative, where members inspire medical students to consider pathology as their specialty as they progress in their training. Witnessing members sharing their zeal for pathology with the next generation has proved to be not only inspiring but also crucial in shaping the future of the field.

Drawing from his experiences as a CEO of various professional associations, Fraser delineates the unique corporate structure of associations, where members essentially serve as the owners and governors of the organization. He emphasizes the importance of generating value across various domains, from advocacy and education to fostering community, all of which are driven by members’ dedication to the profession rather than a profit-centric approach.

Establishing partnerships with other organizations to cultivate a diverse talent pool of executives within the industry, Fraser highlights the success of the Diverse Executives Leading in Public Health (DELPH) program, which he initiated at the Association of State and Territorial Health Officials. This program concentrates on developing leadership competencies among emerging leaders from underrepresented groups in public health management, enabling them to ascend to executive leadership positions in public health organizations and community groups.

With a repertoire of over 40 peer-reviewed scientific publications and five books on strategic leadership and public health, Fraser’s passion for disseminating ideas is palpable. As a “pracademic”, he amalgamates practical and academic approaches to offer insights on leadership and strategy theories in real-world scenarios. His collaborative work with top-tier professionals has yielded substantial contributions to the literature on public health, underscoring his commitment to enhancing leadership and management practices in the public health domain.